Výsledky vyhledávání

Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell

Autor: J, Mora, N K, Cheung, G, Juan, P, Illei, I, Cheung, M, Akram, S, Chi, M, Ladanyi, C, Cordon-Cardo, W L, Gerald

Publikováno v: Cancer research. 61(18)

The coexistence of neuroblastic and Schwannian stromal (SS) cells in differentiating neuroblastoma (NB), and derivation of Schwannian-like cells from neuroblastic clones in vitro, were accepted previously as evidence of a common pluripotent tumor ste

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22d9c2db36568eaa0382b050bac1a4d0
https://pubmed.ncbi.nlm.nih.gov/12025836

Zobrazit plný text záznamu

Biological behavior of human breast cancer micrometastases

Autor: N, Klauber-DeMore, K J, Van Zee, I, Linkov, P I, Borgen, W L, Gerald

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 7(8)

Clinically undetectable micrometastases may account for disease recurrence in breast cancer patients after variable disease-free intervals. However, little is known about the cellular mechanisms controlling human breast cancer micrometastases. We com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2f71db3a7273f44cc57dd1dbf32c7192
https://pubmed.ncbi.nlm.nih.gov/11489823

Zobrazit plný text záznamu

Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma

Autor: K, Kramer, W L, Gerald, B H, Kushner, S M, Larson, M, Hameed, N K, Cheung

Publikováno v: Medical and pediatric oncology. 36(1)

Gangliosicle GD2 is abundant on human neuroblastoma (NB). Monoclonal antibody 3F8 targeted to GD2 may have imaging and therapeutic potential. Antigen-negative clones can escape immune-mediated attack leading to clinical resistance or recurrence.Among

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3bb3bbb95154791e8cdc05fe9809eab3
https://pubmed.ncbi.nlm.nih.gov/11464881

Zobrazit plný text záznamu

Clinically critical impact of molecular genetic studies in pediatric solid tumors

Autor: B H, Kushner, M P, LaQuaglia, N K, Cheung, K, Kramer, A C, Hamelin, W L, Gerald, M, Ladanyi

Publikováno v: Medical and pediatric oncology. 33(6)

Standard cytogenetic techniques are time-consuming and often not informative with solid tumors. In contrast, the reverse transcriptase-polymerase chain reaction (RT-PCR) is a readily available technique that can rapidly detect tumor-specific chromoso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7fdac13f11dea9d02627734a49cd3e71
https://pubmed.ncbi.nlm.nih.gov/10573575

Zobrazit plný text záznamu

Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis

Autor: P, Cole, M, Ladanyi, W L, Gerald, N K, Cheung, K, Kramer, M P, LaQuaglia, B H, Kushner

Publikováno v: Medical and pediatric oncology. 32(2)

The identification of recently described nonrandom chromosomal defects specific for various small round-cell and spindle-cell sarcomas can eliminate diagnostic uncertainty arising from the clinical and histopathologic overlap of soft tissue neoplasms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::06c0517781330f37c6392b52cb6f86fb
https://pubmed.ncbi.nlm.nih.gov/10696138

Zobrazit plný text záznamu

Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma

Autor: K, Kramer, W L, Gerald, B H, Kushner, S M, Larson, M, Hameed, N K, Cheung

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 4(9)

Ganglioside GD2 is abundant on human neuroblastoma (NB). Monoclonal antibody 3F8 targeted to GD2 may have imaging and therapeutic potential. Antigen-negative clones can escape immune-mediated attack, leading to clinical resistance or recurrence. Amon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bd231f85d7e50c04d7757e4779b9b101
https://pubmed.ncbi.nlm.nih.gov/9748131

Zobrazit plný text záznamu

Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience

Autor: I J, Dunkel, W L, Gerald, N S, Rosenfield, E W, Strong, D H, Abramson, F, Ghavimi

Publikováno v: Medical and pediatric oncology. 30(1)

Patients with bilateral retinoblastoma are well recognized to have a high risk of developing a second malignancy, but there are little published data regarding the outcome of these patients following treatment.We identified 15 patients with a history

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::05bc29d299fe575535bd04c8e81f2b91
https://pubmed.ncbi.nlm.nih.gov/9371391

Zobrazit plný text záznamu

Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma

Autor: R I, Brody, T, Ueda, A, Hamelin, S C, Jhanwar, J A, Bridge, J H, Healey, A G, Huvos, W L, Gerald, M, Ladanyi

Publikováno v: The American journal of pathology. 150(3)

The pathogenesis of myxoid chondrosarcoma (CS) is poorly understood. A recurrent translocation, t(9;22) (q22;q12), has been recognized in CS, specifically in extraskeletal myxoid CS. Recently, this translocation has been shown to represent a rearrang

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a6e56080bbce5cf27ea9c6a6b91680c6
https://pubmed.ncbi.nlm.nih.gov/9060841

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání